Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence.

Maes ML, Fixen DR, Linnebur SA.

Ther Adv Drug Saf. 2017 Sep;8(9):273-297. doi: 10.1177/2042098617715381. Epub 2017 Jun 29. Review.

2.

Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System.

Wang L, Li M, Cao Y, Han Z, Wang X, Atkinson EJ, Liu H, Amin S.

Sci Rep. 2017 Jul 17;7(1):5527. doi: 10.1038/s41598-017-05552-1.

3.

A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety.

Dubcenco E, Beers-Block PM, Kim LP, Schotland P, Levine JG, McCloskey CA, Bashaw ED.

Clin Transl Sci. 2017 Sep;10(5):387-394. doi: 10.1111/cts.12475. Epub 2017 Jun 15.

4.

Acid-suppressive medications and risk of fracture: an updated meta-analysis.

Cai D, Feng W, Jiang Q.

Int J Clin Exp Med. 2015 Jun 15;8(6):8893-904. eCollection 2015.

5.

Bone fracture and the interaction between bisphosphonates and proton pump inhibitors: a meta-analysis.

Yang SD, Chen Q, Wei HK, Zhang F, Yang DL, Shen Y, Ding WY.

Int J Clin Exp Med. 2015 Apr 15;8(4):4899-910. eCollection 2015.

6.

Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update.

Moayyedi P, Yuan Y, Leontiadis G; CAG Clinical Affairs.

Can J Gastroenterol. 2013 Oct;27(10):593-5. No abstract available.

7.

Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk.

Moore RA, Derry S, Simon LS, Emery P.

Pain Pract. 2014 Apr;14(4):378-95. doi: 10.1111/papr.12100. Epub 2013 Aug 14. Review.

8.

Chronic proton pump inihibitor therapy and calcium metabolism.

Yang YX.

Curr Gastroenterol Rep. 2012 Dec;14(6):473-9. doi: 10.1007/s11894-012-0290-4. Review.

9.

The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study.

Fraser LA, Leslie WD, Targownik LE, Papaioannou A, Adachi JD; CaMos Research Group.

Osteoporos Int. 2013 Apr;24(4):1161-8. doi: 10.1007/s00198-012-2112-9. Epub 2012 Aug 14.

10.

Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study.

Lalmohamed A, de Vries F, Bazelier MT, Cooper A, van Staa TP, Cooper C, Harvey NC.

BMJ. 2012 Aug 3;345:e5085. doi: 10.1136/bmj.e5085.

11.

The initiative on hip fractures of the Veneto Region.

Rossini M, Caimmi C, Giannini S, Sella S, Mattarei A, Lovato R, Piazza I, Fassio A, Persi P, Benetollo PP, Adami S.

Clin Cases Miner Bone Metab. 2012 Jan;9(1):45-9. Epub 2012 May 29.

12.

The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos).

Targownik LE, Leslie WD, Davison KS, Goltzman D, Jamal SA, Kreiger N, Josse RG, Kaiser SM, Kovacs CS, Prior JC, Zhou W; CaMos Research Group.

Am J Gastroenterol. 2012 Sep;107(9):1361-9. doi: 10.1038/ajg.2012.200. Epub 2012 Jul 10. Erratum in: Am J Gastroenterol. 2013 Jan;108(1):157.

13.

Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study.

Khalili H, Huang ES, Jacobson BC, Camargo CA Jr, Feskanich D, Chan AT.

BMJ. 2012 Jan 30;344:e372. doi: 10.1136/bmj.e372.

14.

Factors associated with the initiation of proton pump inhibitors in corticosteroid users.

Munson JC, Wahl PM, Daniel G, Kimmel SE, Hennessy S.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):366-74. doi: 10.1002/pds.2350. Epub 2012 Jan 25.

15.

Knee arthroplasty and risk of hip fracture: a population-based, case-control study.

Lalmohamed A, Opdam F, Arden NK, Prieto-Alhambra D, van Staa T, Leufkens HG, de Vries F.

Calcif Tissue Int. 2012 Feb;90(2):144-50. doi: 10.1007/s00223-011-9558-1. Epub 2011 Dec 18.

16.

Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.

Lalmohamed A, Welsing PM, Lems WF, Jacobs JW, Kanis JA, Johansson H, De Boer A, De Vries F.

Osteoporos Int. 2012 Mar;23(3):861-9. doi: 10.1007/s00198-011-1852-2. Epub 2011 Nov 26.

17.

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.

Yu EW, Bauer SR, Bain PA, Bauer DC.

Am J Med. 2011 Jun;124(6):519-26. doi: 10.1016/j.amjmed.2011.01.007.

18.

Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.

Eom CS, Park SM, Myung SK, Yun JM, Ahn JS.

Ann Fam Med. 2011 May-Jun;9(3):257-67. doi: 10.1370/afm.1243.

Supplemental Content

Support Center